$10.04
-0.06-0.59%
At close: Aug 14, 5:00 PM EST
$10.05
0.01020.1%
After Hours: 6:50 PM EST
Ocular Therapeutix Inc
OCULNASDAQ
Ocular Therapeutix Earnings & Forecasts
Ocular Therapeutix (OCUL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Ocular Therapeutix Guidance
Ocular Therapeutix (OCUL) last issued guidance on November 7, 2023 for fiscal year 2023. The company guided revenue in the range of $60M - $60M for the period.
Compared to prior guidance, Ocular Therapeutix raised its revenue forecast from a prior range of $55M - $60M.
Ocular Therapeutix has issued 4 guidance updates between March 6, 2023 and November 7, 2023. During this period, the company raised its outlook 1 time, reflecting management's growing confidence in business performance.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.39 | $-0.32 | $-0.33 | $-0.36 |
| Actual | $-0.35 | $-0.40 | $-0.29 | $-0.38 |
| Surprise | +10.3% | -25.0% | +12.1% | -5.56% |
| Revenue | ||||
| Estimate | $13.1M | $12.7M | $15.7M | $14.1M |
| Actual | $13.5M | $10.8M | $13.3M | $14.5M |
| Surprise | +2.89% | -15.1% | -15.7% | +3.25% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.35 | $-0.37 | $-0.38 | $-0.37 |
| Revenue | ||||
| Consensus | $14.3M | $14.1M | — | — |
